NCT07411469

Brief Summary

Sepsis is a life-threatening condition caused by a dysregulated host response to infection, leading to organ dysfunction. Septic shock, a severe form of sepsis, is characterized by persistent hypotension and cellular/metabolic abnormalities despite adequate fluid resuscitation. It is associated with high mortality rates globally, necessitating timely diagnosis and treatment. Fluid resuscitation and vasopressor use are cornerstones of management, but they must be tailored to the individual to prevent complications such as fluid overload.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 10, 2025

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

January 30, 2026

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 13, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2026

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 20, 2026

Completed
Last Updated

February 13, 2026

Status Verified

May 1, 2025

Enrollment Period

1 year

First QC Date

January 30, 2026

Last Update Submit

February 8, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Septic Shock Evaluation

    Assessment of the participants which suffering from Septic Shock by using Inferior Vena Cava Collapsibility and Electrical Cardiometry for assisting the Fluid Responsiveness

    Two Hours

Study Arms (2)

Electrical Cardiometry Monitoring

Non-invasive assessment of stroke volume and cardiac output using electrical cardiometry at baseline and after fluid challenge.

Procedure: Cardiometry

Inferior Vena Cava Collapsibility Assessment Group

Thirty patients with septic shock will undergo bedside ultrasound assessment of the inferior vena cava to measure the collapsibility index for evaluation of fluid responsiveness. Measurements will be performed as part of routine clinical monitoring without any alteration to standard clinical management.

Procedure: Cardiometry

Interventions

CardiometryPROCEDURE

Bedside ultrasound measurement of inferior vena cava diameters during the respiratory cycle to calculate the collapsibility index at baseline and after fluid challenge

Also known as: Inferior Vena Cava Ultrasound Assessment
Electrical Cardiometry MonitoringInferior Vena Cava Collapsibility Assessment Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Study protocol approval prior to implementation of the research will be obtained from Faculty of Medicine, Menoufia University Research Ethics Committee. Parents were informed about the study purpose and its consequences, confirming confidentiality of data. A signed informed consent was a pre-requisite for the study. Type of study: Prospective study Site of study: This study will be conducted at the Intensive Care Unit, Faculty of Medicine, Menoufia university Hospital. The study population: The study will include (60) septic Shock patients who admitted to Intensive Care Unit.

You may qualify if:

  • Patients Diagnosed with Hypotensive Sepsis: Patients must meet the clinical criteria for sepsis according to the Sepsis-3 definitions, including evidence of infection and hypotension despite adequate fluid resuscitation. Hypotension is defined as systolic blood pressure \<90 mmHg or mean arterial pressure (MAP) \<65 mmHg.
  • BMI ≥18.5 and ≤40 kg/m²: Patients will be included regardless of BMI, as long as it falls within the normal to overweight/obese range. Extremes of BMI (e.g., \<18.5 or \>40) may be excluded due to the potential influence on peripheral perfusion measurements.
  • American Society of Anesthesiologists (ASA) Physical Status Classification as:
  • ASA Score I-III: Patients with an ASA physical status score of I (healthy patients), II (mild systemic disease), or III (severe systemic disease) will be included. Patients with ASA IV or V (those with severe systemic disease that is a constant threat to life) will be excluded due to potential confounding factors.

You may not qualify if:

  • \- Cardiac Conditions: Significant valvular heart diseases, such as severe mitral or aortic regurgitation, which can affect hemodynamic assessments.
  • Presence of major cardiac arrhythmias, including atrial fibrillation or frequent ectopic beats, as these can interfere with accurate measurement of fluid responsiveness.
  • \- Renal Considerations: Patients undergoing renal replacement therapy or those with end-stage renal disease, as fluid balance and responsiveness may be altered.
  • Pregnancy Hemodynamic changes during pregnancy (e.g., increased cardiac output and altered vascular resistance) differ significantly from septic shock.
  • Patients with a body mass index (BMI) greater than 40 kg/m² Obesity can affect the accuracy of non-invasive monitoring techniques with poor window.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Menoufia University Hospital

Shibīn al Kawm, Menoufia, 23511, Egypt

RECRUITING

MeSH Terms

Conditions

Shock, Septic

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShock

Study Officials

  • Noha Abdallah Afify, Professor

    Anaesthesia, Intensive Care and Pain Management, Faculty of Medicine, Menoufia University

    STUDY CHAIR

Central Study Contacts

Ahmed Mohamed Fared, MSc

CONTACT

Mohamed Fathy Abdelaziz, Lecturer

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident at Anaesthesia, Intensive Care and Pain Management Department

Study Record Dates

First Submitted

January 30, 2026

First Posted

February 13, 2026

Study Start

May 10, 2025

Primary Completion

May 10, 2026

Study Completion

May 20, 2026

Last Updated

February 13, 2026

Record last verified: 2025-05

Locations